Kaur Simerdip, Patel Bhupendra C K, Collen Alanna, Malhotra Raman
Department of Ophthalmology, University Hospitals Sussex NHS Foundation Trust, Sussex Eye Hospital, Eastern Road, Brighton, BN2 5BF, UK.
Corneoplastic Unit, Queen Victoria Hospital, East Grinstead, RH19 3DZ, UK.
Eye (Lond). 2025 Feb;39(3):436-448. doi: 10.1038/s41433-024-03517-z. Epub 2024 Dec 19.
The human microbiome has progressively been recognised for its role in various disease processes. In ophthalmology, complex interactions between the gut and distinct ocular microbiota within each structure and microenvironment of the eye has advanced our knowledge on the multi-directional relationships of these ecosystems. Increasingly, studies have shown that modulation of the microbiome can be achieved through faecal microbiota transplantation and synbiotics producing favourable outcomes for ophthalmic diseases. As ophthalmologists, we are obliged to educate our patients on measures to cultivate a healthy gut microbiome through a range of holistic measures. Further integrative studies combining microbial metagenomics, metatranscriptomics and metabolomics are necessary to fully characterise the human microbiome and enable targeted therapeutic interventions.
人类微生物组在各种疾病过程中的作用已逐渐得到认可。在眼科领域,肠道与眼睛各个结构和微环境中独特的眼部微生物群之间的复杂相互作用,增进了我们对这些生态系统多向关系的认识。越来越多的研究表明,通过粪便微生物群移植和合生元可以调节微生物组,从而为眼科疾病带来良好的治疗效果。作为眼科医生,我们有责任通过一系列整体措施,教育患者采取措施培养健康的肠道微生物组。有必要开展结合微生物宏基因组学、宏转录组学和代谢组学的进一步综合研究,以全面表征人类微生物组,并实现有针对性的治疗干预。